"La Polyclinique Vauban est une polyclinique médico-chirurgicale proposant également des soins de suite et de réadaptation. Elle regroupe plus de 80 praticiens et une équipe de 420 personnes. Elle est pourvue d’un plateau technique très complet et possède 260 lits."

During the past decade, Polyclinique Vauban conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Polyclinique Vauban" #1 sponsor was "Elsan" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Biotronik AG" with 1 trials sponsored and "Centre Oscar Lambret" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique Vauban" #1 collaborator was "Biotronik France" with 1 trials as a collaborator, "Bordeaux PharmacoEpi" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "National Cancer Institute, France" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique Vauban" are "Atrial Fibrillation" (2 trials), "Cardiovascular Disease" (2 trials), "Coronary Artery Disease" (2 trials), "Abdominal Aortic Aneurysm" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Polyclinique Vauban" in a lesser frequency.

Most popular intervention types in "Polyclinique Vauban" are "Drug" (5 trials), "Other" (4 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Atrial flutter ablation" (1 trials), "Atrial flutter ablation and pulmonary vein isolation" (1 trials) and "Clopidogrel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique Vauban" are 15 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Polyclinique Vauban". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Polyclinique Vauban, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique Vauban, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Polyclinique Vauban has several departments that took part in Clinical trials: "Service de cardiologie, Polyclinique Vauban" - 2 trials